Survival after allogeneic bone marrow transplantation (BMT) in patients randomised into a trial of IFN-alpha versus chemotherapy: No significant adverse effect of prolonged IFN-alpha administration. - Shepherd, P; Richards, S; Allan, N (BLOOD, 1995)